Brain imaging AI leader icometrix raises US$ 18 million in new funding
Company’s technology will transform care for patients with brain disorders and injuries
Leuven, Belgium, Geneva, Switzerland, Boston, USA: 13 May 2019 − icometrix, the global expert in brain imaging Artificial Intelligence solutions, has raised $18 million through a partnership led by Forestay Capital alongside Optum Ventures and existing investor Capricorn Venture Partners.
icometrix’s icobrain software, which is both CE-marked and FDA-cleared, extracts clinically meaningful information from brain MRI and CT scans of patients with neurological disorders, such as Multiple Sclerosis, Alzheimer’s disease and dementia, and traumatic brain injury. The icobrain AI solutions are already used in more than 100 hospitals and imaging center networks worldwide, and this number is increasing fast. In addition, 4 out of the Top 5 pharmaceutical companies are using icobrain in their studies.
More info on icometrix’ website.